BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37060647)

  • 21. [2022 WHO classification of renal cell carcinomas: Focus on papillary renal cell carcinoma].
    Bellal S; Kammerer-Jacquet SF; Rioux-Leclercq N;
    Ann Pathol; 2024 May; ():. PubMed ID: 38729793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic analysis and clinicopathological features of ALK-rearranged renal cell carcinoma in a large series of resected Chinese renal cell carcinoma patients and literature review.
    Yu W; Wang Y; Jiang Y; Zhang W; Li Y
    Histopathology; 2017 Jul; 71(1):53-62. PubMed ID: 28199742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morphologic, Molecular, and Taxonomic Evolution of Renal Cell Carcinoma: A Conceptual Perspective With Emphasis on Updates to the 2016 World Health Organization Classification.
    Udager AM; Mehra R
    Arch Pathol Lab Med; 2016 Oct; 140(10):1026-37. PubMed ID: 27684973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis of uncommon renal epithelial neoplasms: performances of fluorescence in situ hybridization.
    Beaumont M; Dugay F; Kammerer-Jacquet SF; Jaillard S; Cabillic F; Mathieu R; Verhoest G; Bensalah K; Rioux-Leclercq N; Belaud-Rotureau MA;
    Hum Pathol; 2019 Oct; 92():81-90. PubMed ID: 31437522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Xp11.2 translocation renal cell carcinoma with SMARCB1 (INI1) inactivation in adult end-stage renal disease: a case report.
    Yu L; Li J; Xu S; Navia Miranda M; Wang G; Duan Y
    Diagn Pathol; 2016 Oct; 11(1):98. PubMed ID: 27733182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reappraisal of Morphologic Differences Between Renal Medullary Carcinoma, Collecting Duct Carcinoma, and Fumarate Hydratase-deficient Renal Cell Carcinoma.
    Ohe C; Smith SC; Sirohi D; Divatia M; de Peralta-Venturina M; Paner GP; Agaimy A; Amin MB; Argani P; Chen YB; Cheng L; Colecchia M; Compérat E; Werneck da Cunha I; Epstein JI; Gill AJ; Hes O; Hirsch MS; Jochum W; Kunju LP; Maclean F; Magi-Galluzzi C; McKenney JK; Mehra R; Nesi G; Osunkoya AO; Picken MM; Rao P; Reuter VE; de Oliveira Salles PG; Schultz L; Tickoo SK; Tomlins SA; Trpkov K; Amin MB
    Am J Surg Pathol; 2018 Mar; 42(3):279-292. PubMed ID: 29309300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The classification of pediatric and young adult renal cell carcinomas registered on the children's oncology group (COG) protocol AREN03B2 after focused genetic testing.
    Cajaiba MM; Dyer LM; Geller JI; Jennings LJ; George D; Kirschmann D; Rohan SM; Cost NG; Khanna G; Mullen EA; Dome JS; Fernandez CV; Perlman EJ
    Cancer; 2018 Aug; 124(16):3381-3389. PubMed ID: 29905933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. "Renal Cell Carcinoma With Leiomyomatous Stroma" Harbor Somatic Mutations of TSC1, TSC2, MTOR, and/or ELOC (TCEB1): Clinicopathologic and Molecular Characterization of 18 Sporadic Tumors Supports a Distinct Entity.
    Shah RB; Stohr BA; Tu ZJ; Gao Y; Przybycin CG; Nguyen J; Cox RM; Rashid-Kolvear F; Weindel MD; Farkas DH; Trpkov K; McKenney JK
    Am J Surg Pathol; 2020 May; 44(5):571-581. PubMed ID: 31850909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ALK rearrangement in TFE3-positive renal cell carcinoma: Alternative diagnostic option to exclude Xp11.2 translocation carcinoma.
    Zhu Y; Liu N; Guo W; Pu X; Guo H; Gan W; Li D
    Pathol Res Pract; 2020 Dec; 216(12):153286. PubMed ID: 33197836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chromophobe renal cell carcinoma: current and controversial issues.
    Moch H; Ohashi R
    Pathology; 2021 Jan; 53(1):101-108. PubMed ID: 33183792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minimally invasive cytologic evaluation leading to the diagnosis of TFE3-rearranged renal cell carcinoma: A case report.
    Gama A; Sukhanova M; Choy B
    Diagn Cytopathol; 2022 Dec; 50(12):E382-E385. PubMed ID: 35975764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TFE3 and TFEB-rearranged renal cell carcinomas: an immunohistochemical panel to differentiate from common renal cell neoplasms.
    Caliò A; Marletta S; Brunelli M; Pedron S; Portillo SC; Segala D; Bariani E; Gobbo S; Netto G; Martignoni G
    Virchows Arch; 2022 Dec; 481(6):877-891. PubMed ID: 35980471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kidney Tumors: New and Emerging Kidney Tumor Entities.
    Siadat F; Mansoor M; Hes O; Trpkov K
    Clin Lab Med; 2023 Jun; 43(2):275-298. PubMed ID: 37169446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Provisional renal cell carcinoma subsets following the 2016 WHO classification].
    Jenei A; Hes O; Kuthi L
    Orv Hetil; 2020 Jan; 161(3):83-94. PubMed ID: 31928058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ALK-rearranged renal cell carcinomas in children.
    Cajaiba MM; Jennings LJ; Rohan SM; Perez-Atayde AR; Marino-Enriquez A; Fletcher JA; Geller JI; Leuer KM; Bridge JA; Perlman EJ
    Genes Chromosomes Cancer; 2016 May; 55(5):442-51. PubMed ID: 26773439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kidney Tumors: New and Emerging Kidney Tumor Entities.
    Siadat F; Mansoor M; Hes O; Trpkov K
    Surg Pathol Clin; 2022 Dec; 15(4):713-728. PubMed ID: 36344185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The evolving classification of renal cell neoplasia.
    Delahunt B; Srigley JR
    Semin Diagn Pathol; 2015 Mar; 32(2):90-102. PubMed ID: 25753529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Merlin immunohistochemistry is useful in diagnosis of tumours within the spectrum of biphasic hyalinizing psammomatous renal cell carcinoma.
    Collins K; Hwang M; Antic T; Paintal A; Argani P; Matoso A; Gopinath A; Baskovich B; Mehra R; Williamson SR; Idrees MT; Barletta JA; Anderson WJ; Hirsch MS; Hornick JL; Acosta AM
    Histopathology; 2022 Nov; 81(5):577-586. PubMed ID: 35971742
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Wangsiricharoen S; Zhong M; Ranganathan S; Matoso A; Argani P
    Int J Surg Pathol; 2021 Oct; 29(7):808-814. PubMed ID: 33729862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.
    Trpkov K; Hes O; Williamson SR; Adeniran AJ; Agaimy A; Alaghehbandan R; Amin MB; Argani P; Chen YB; Cheng L; Epstein JI; Cheville JC; Comperat E; da Cunha IW; Gordetsky JB; Gupta S; He H; Hirsch MS; Humphrey PA; Kapur P; Kojima F; Lopez JI; Maclean F; Magi-Galluzzi C; McKenney JK; Mehra R; Menon S; Netto GJ; Przybycin CG; Rao P; Rao Q; Reuter VE; Saleeb RM; Shah RB; Smith SC; Tickoo S; Tretiakova MS; True L; Verkarre V; Wobker SE; Zhou M; Gill AJ
    Mod Pathol; 2021 Jul; 34(7):1392-1424. PubMed ID: 33664427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.